FF
Insider selling
Foundation Fighting Blindness Retinal Degeneration Fund sold $7.4M of Opus Genetics, Inc. (IRD) stock
Foundation Fighting Blindness Retinal Degeneration Fund, Dir of Opus Genetics, Inc. (IRD), sold 1,700,000 shares of IRD stock worth $7.4M, per an SEC Form 4 filed May 20, 2026.
It was an open-market sale.
The trade happened on May 18, 2026, 2 days before it was made public.
IRD has moved +17.6% since the trade date, from $4.44 to $5.22 (Sep 21, 2026 close).
- Traded
- May 18, 2026
- Disclosed
- May 20, 2026
- Filing delay
- 2 days
- Price since
- +17.6%
- Role
- Dir
- Source
- SEC Form 4
More IRD insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.